Fritextsökning
Innehållstyper
-
Det satsas miljarder - men allt faller platt
I avsaknad av ledarskap gror frågorna, skriver Life Science Swedens chefredaktör Ingrid Heath.
-
Hallå där Peter Bramberg...
... som ansvarar för life science på Invest Sweden, vad är viktigast att den kommande regeringen genomför för life science-sektorn?
-
Norwegian entrance in EU technology network
The Norwegian University of Science and Technology joins the European Science Business Network of prominent European research institutions.
-
VTT in brief
VTT is a broad science cluster with research within applied materials, chemical and biochemical processes, energy, industrial systems management, information an...
-
New faces in Pronova Biopharma team
The Norwegian company Pronova Biopharma has recently changed the management team structure.
-
Ny design på klinstudie
I ett samarbete mellan FDA, NIH och läkemedelsindustrin utvärderas ett flertal behandlingar i samma studie.
-
Fewer visitors but satisfied exhibitors
Biotech Forum Scanlab attracted fewer visitors than in 2008. Exhibition manager Bo Rasmussen is content, claiming that the exhibitors are very satisfied.
-
Swedish nanotech crosses the Atlantic
Genovis signs distribution agreement Finnzymes in US.
-
New firm based on SLU research
Four researchers at the Swedish University of Agricultural Sciences, SLU, has recently founded a new nanotech company.
-
Finnish-Dutch engineering cooperation continues
The University of Helsinki and ASM International renew a fice year research agreement on Atomic Layer Deposition.
-
Samarbete med universitet ska gynna Novo
I Combine samarbetar sex svenska universitet för att skapa bättre förståelse kring inflammatoriska sjukdomar. Bolaget ska nu delta i ett projekt för att arbeta ...
-
Apoteket gets new vice CEO
The Swedish government company Apoteket has recently appointed a vice CEO.
-
Take off for this year's fair
More visitors than previously were preregistered when Scanlab and Biotech Forum opened today. But the future of the exhibitions and their design is uncertain.
-
Orexo opens doors eastwards
The drug delivery company has signed a deal for selling a cancer pain treatment in China. "An ideal partner for us" says Torbjörn Bjerke, CEO of Orexo.
-
New member to Active board
The Election Committee of Active Biotech proposes a very experienced financial sector executive to join the company board. Five existing members are also to be ...
-
New NO product reduces diabetic pain
The Swedish medtech company Nolabs has announced that it has achieved an important milestone in the development of a new line of products.
-
Mathematician new dean at DTU
On January 1st the Technical University of Denmark, DTU, got a new dean, recruited from the department of Mathematics.
-
Datorn som matchmaker
Datorbaserade modeller kan användas för att förstå interaktioner mellan två läkemedel eller förutsäga biverkningar. - Det blir också möjligt att identifiera pro...
-
Symphogen buys tumor blocking technology
The seller is a pioneer in developing ligand traps to treat cancer and other diseases. "An excellent fit with our scientific and strategic focus," said Kirsten ...
-
Success fee to Bioinvent and partner
The cancer collaboration started last year. After successful technology transfer the two partner companies now receives 5 million euro from pharma giant Roche.
-
Polymer guru new dean at DTU
The Technical University of Denmark, DTU, has appointed a well-known profile from the Polymer Center as a new dean.
-
Recipharm launches into biologics manufacturing
Recently a Swedish biomanufacturing facility transfers from Astrazeneca to Recipharm Biologics.
-
Så blir Mölndal som Astrazenecas nya fokus
Bra medarbetare, kompetens och förutsättningar är anledningen till att Astrazeneca behåller forskningen i Mölndal enligt Anders Ekblom, vd för Astrazeneca Sverige.
-
Age essential when testing drugs
Anders Rane has been arguing that genes and age are both important factors in understanding how medicines affect individuals. Only last year, the EU established...